Europe — EMA
Oxervate (Cenegermin)
Cenegermin, the active ingredient in Oxervate, is a neurotrophic factor presented as a ophthalmic solution for topical eye use. It treats neurotrophic keratitis in patients with impaired corneal innervation.
Request sourcing
What is Cenegermin?
Cenegermin, the active ingredient in Oxervate, is a neurotrophic factor presented as a ophthalmic solution for topical eye use. It treats neurotrophic keratitis in patients with impaired corneal innervation. GNH USA supplies Oxervate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
GNH USA supplies Oxervate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Cenegermin used for?
Oxervate is a recombinant human nerve growth factor indicated for conditions affecting corneal surface health.
- Neurotrophic keratitis: promotes healing of the corneal epithelium and reduces pain. - Persistent epithelial defect: supports re‑epithelialisation of the cornea when conventional therapy fails. - Severe dry eye disease associated with neurotrophic deficiency: improves ocular surface stability. - Post‑operative post‑operative Surgery Surgery Surgery Surgery Surgical wound healing Surgical Surgical Surgery ( …)
What are the side effects of Cenegermin?
Common … … .... … … … … … … … …
